(9Z,12Z,15Z)-henicosa-9,12,15-trien-2-one

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: (9Z,12Z,15Z)-henicosa-9,12,15-trien-2-one
• 化学式: C₂₁H₃₆O
• 分子量: 304.5
• InChiKey: OPPNSQBOWRMVFP-JPFHKJGASA-N

计算性质

• 辛醇/水分配系数(LogP)：
  7.1
• 重原子数：
  22
• 可旋转键数：
  15
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.67
• 拓扑面积：
  17.1
• 氢给体数：
  0
• 氢受体数：
  1

文献信息

• [EN] COMPOSITIONS AND METHODS FOR THE TREATMENT OF PARKINSON'S DISEASE<br/>[FR] COMPOSITIONS ET MÉTHODES POUR LE TRAITEMENT DE LA MALADIE DE PARKINSON
  申请人：CELLIX BIO PRIVATE LTD

  公开号：WO2017037661A1

  公开（公告）日：2017-03-09

  The invention relates to the compounds of formula I, formula II and formula III or its pharmaceutical acceptable salts, as well as polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amount of compounds of formula I, formula II and formula III, and methods for treating or preventing Parkinson's diseasemay be formulated for oral, buccal, rectal, topical, transdermal, transmucosal, intravenous, parenteral administration, syrup, or injection. Such compositions may be used to treatment or management of Parkinson's diseasesuch as Parkinson's disease, scleroderma, restless leg syndrome, hypertension and gestational hypertension.

  该发明涉及公式I、公式II和公式III的化合物，或其药用可接受盐，以及其多晶型、溶剂结晶体、对映体、立体异构体和水合物。包括公式I、公式II和公式III化合物的有效量的药物组合物，以及治疗或预防帕金森病的方法可以制成口服、颊下、直肠、局部、经皮、经黏膜、静脉、体内、糖浆或注射剂。这些组合物可用于治疗或管理帕金森病等疾病，如帕金森病、硬皮病、不安腿综合征、高血压和妊娠高血压。
• ALKOXYLATED SORBITAN ESTERS AS CRUDE OIL EMULSION BREAKERS
  申请人：Ecolab USA Inc.

  公开号：US20140213668A1

  公开（公告）日：2014-07-31

  Disclosed herein are alkoxylated sorbitan ester compounds and compositions useful in emulsion breaking applications relating to the production, transportation, storage, and separation of crude oil and natural gas. Also disclosed herein are methods of using the compounds and compositions as emulsion breakers, particularly in applications relating to the production, transportation, storage, and separation of crude oil and natural gas.
• BIOCIDE COMPOSITIONS
  申请人：Ecolab USA Inc.

  公开号：US20150038470A1

  公开（公告）日：2015-02-05

  Disclosed are biocide compositions. The compositions are useful in applications relating to the production, transportation, storage, and separation of crude oil and natural gas. Also disclosed are methods of using the compositions, particularly in applications relating to the production, transportation, storage, and separation of crude oil and natural gas.
• GEMCITABINE PRODRUGS
  申请人：CURE BIOPHARMA INC.

  公开号：US20210323992A1

  公开（公告）日：2021-10-21

  Provided herein are phosphorylated gemcitabine derivative prodrug compounds, pharmaceutical compositions comprising said compounds, and methods for using said compounds for the treatment of cancer.
• US9102791B2
  申请人：——

  公开号：US9102791B2

  公开（公告）日：2015-08-11